Searched for
CRAM SPACE
77 headless skeletons found in a 7,000-year-old ditch in Slovakia, and the only skull left belonged to a childArchaeologists in Slovakia unearthed dozens of headless human skeletons. The remains are over 7,000 years old. Skulls were carefully remove...- Huawei touts new chipmaking technology to sidestep US restrictionsChinese tech giant Huawei said on Monday it had developed a new way of making semiconductors that could get around its US-enforced lack of ...
- Builder denied proper parking? Know your rights under RERA & key court rulingsHomebuyers facing parking disputes with builders now have legal recourse. Judicial precedents and RERA guidelines offer clarity on issues l...
- Miller, Axar keep DC alive in IPL with record chase; PBKS lose four in a rowDelhi Capitals achieved a record chase at Dharamsala, defeating Punjab Kings by three wickets. David Miller and captain Axar Patel led the ...
- Wait 1-2 quarters more before turning positive in IT; CRAMS safer in pharma: Nischal MaheshwariMarket expert Nischal Maheshwari suggests caution regarding the IT sector due to macroeconomic uncertainties. He prefers stock-specific app...
- Devang Mehta on what themes work best for him in pharma spaceDevang Mehta discusses the bullish themes in the pharma space, particularly MNC pharma companies like Abbot India. These companies have a h...
- CRAMS could be new wealth creators in pharma spaceMore and more pharma cos are finding it profitable to outsource all aspects from R&D to commercialisation to trusted partners in low-cost c...
- PI Industries a safe bet among agri-based stocks: Madhusudan SardaThe company is dependent on domestic market and has a substantial presence in contract research and manufacturing services (CRAMS), says Sa...
- Buy Strides Arcolab from a long term perspective: Sonam Udasi"If you have a long term, go for stocks like Strides Arcolab even Aurobindo Pharma after that huge correction we saw."
- Buy Biocon, Dishman and Divis Laboratories: Avinash GorakshekarWithin the mid-cap pharma kind of opportunity, there are specific slots like CRAMS or typically outsourcing kind of players, which are doin...
- Positive on Glenmark Pharma: Avinash Gorakshekar, Anagram Capital LtdAvinash Gorakshekar, Head Of Research, Anagram Capital Ltd, in a chat with ET Now talks about the pharma stocks.
- 'Target Rs 455 Jubilant Organosys'In a chat with ET Now, Sharmila Joshi, Co-head PCG Sales, Emkay Global Financial Services, talks about the outlook of Jubilant Organosys.
- Obama's tax worries pharma tooApart from IT, the domestic pharma industry is also worried over President Obama's proposal to end tax breaks for US companies, which are e...
- Contract jobs to keep pharma cos healthyBut the slowdown and the liquidity crisis have taken the sheen off auto components, with the focus now shifting to another segment: contrac...
- Pharma R&D offshoring wards off slowdownContract Research & Manufacturing (CRAM) business of pharma companies has picked up pace amidst global economic crisis.
- Buy Dishman Pharma for target Rs 418: ReligareReligare Securities has recommended ‘buy’ on Dishman Pharmaceuticals and has revised the target price to Rs 418, over to a one-year horizon.
- Jubilant hunts for buys abroadJubilant Organosys is evaluating various proposals to acquire companies in the contract research and manufacturing services (CRAMS), drug d...
- Wockhardt plans CRAM play to bag big US, European dealsDomestic pharma major Wockhardt has decided to enter the lucrative contract manufacturing (CRAM) space from the next fiscal.
- Shasun to project R&D identityChennai-based Shasun Chemicals and Drugs is aiming to change its image as a bulk drug manufacturer to one of a research-driven company in t...
- Shasun to project R&D identityThe Chennai-based Shasun Chemicals and Drugs is aiming to change its image as a bulk drug manufacturer to one of a research-driven company ...
Load More
